Millennium Management’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $987K | Buy |
+850,474
| New | +$987K | ﹤0.01% | 3037 |
|
|
2024
Q4 | – | Sell |
-244,640
| Closed | -$2.74M | – | 4383 |
|
|
2024
Q3 | $2.74M | Buy |
244,640
+171,350
| +234% | +$1.92M | ﹤0.01% | 2364 |
|
|
2024
Q2 | $788K | Buy |
73,290
+42,751
| +140% | +$460K | ﹤0.01% | 2991 |
|
|
2024
Q1 | $455K | Buy |
+30,539
| New | +$455K | ﹤0.01% | 3338 |
|
|
2023
Q4 | – | Sell |
-181,884
| Closed | -$3.15M | – | 4424 |
|
|
2023
Q3 | $3.15M | Sell |
181,884
-175,679
| -49% | -$3.05M | ﹤0.01% | 2212 |
|
|
2023
Q2 | $6.48M | Sell |
357,563
-14,240
| -4% | -$258K | ﹤0.01% | 1747 |
|
|
2023
Q1 | $9.89M | Buy |
371,803
+165,072
| +80% | +$4.39M | 0.01% | 1439 |
|
|
2022
Q4 | $4M | Buy |
206,731
+12,849
| +7% | +$248K | ﹤0.01% | 2263 |
|
|
2022
Q3 | $4.05M | Sell |
193,882
-26,331
| -12% | -$550K | ﹤0.01% | 2355 |
|
|
2022
Q2 | $1.76M | Buy |
220,213
+162,146
| +279% | +$1.3M | ﹤0.01% | 2991 |
|
|
2022
Q1 | $407K | Sell |
58,067
-6,196
| -10% | -$43.4K | ﹤0.01% | 4209 |
|
|
2021
Q4 | $868K | Buy |
64,263
+30,867
| +92% | +$417K | ﹤0.01% | 3594 |
|
|
2021
Q3 | $564K | Buy |
33,396
+16,077
| +93% | +$272K | ﹤0.01% | 4086 |
|
|
2021
Q2 | $504K | Sell |
17,319
-46,047
| -73% | -$1.34M | ﹤0.01% | 4201 |
|
|
2021
Q1 | $2.49M | Buy |
63,366
+31,570
| +99% | +$1.24M | ﹤0.01% | 2657 |
|
|
2020
Q4 | $722K | Buy |
31,796
+14,648
| +85% | +$333K | ﹤0.01% | 3057 |
|
|
2020
Q3 | $388 | Sell |
17,148
-52,920
| -76% | -$1.2K | ﹤0.01% | 2950 |
|
|
2020
Q2 | $2.27M | Buy |
+70,068
| New | +$2.27M | ﹤0.01% | 1934 |
|